Hematological parameters in Myeloproliferative neoplasms in Sudanese patients

Impact of JAK2V617F Mutational on Haematologic Features in Sudanese Patients with Essential Thrombocythemia and Thrombotic Risk Assessment

Screening of Arterial Atherosclerosis in JAK2 positive Philadelphia negative myeloproliferative neoplasms among Egyptian patients below 60 years old.

Evaluating The Risk of Thrombosis and Its Relation to JAKII Mutation in Egyptian Myeloproliferative Neoplasm Patients

Myelodysplastic and myeloproliferative neoplasms: Updates on the overlap syndromes

Myelodysplastic Syndromes at Middle East and North Africa (MENA) Centers: Case Study Upper Egypt

FOCAL SEGMENTAL GLOMERULOSCLEROSIS ASSOCLTED WITH MYELOPROLIFERATIVE DISORDER

Pathophysiology of Pulmonary Hypertension in Patients with Myeloproliferative Neoplasms

Carotid Plaque Burden and Neutrophil-Lymphocyte Ratio in Patients with Philadelphia Negative Myeloproliferative Neoplasms and Their Relation to JAK2 V617F Mutation

Expression of JAK2 V617F mutation in chronic myeloproliferative disorders